/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Cardiovascular Biotherapeutics Inc.\n \n\n\n\n\n
Nov 20 8:49 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Feb 24, 2009 8:00 AM EST
\n\n \n CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial - PR Newswire\n \n \n
\n\n Jan 08, 2009 8:02 AM EST
\n\n \n CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial - PR Newswire\n \n \n
\n\n Dec 11, 2008 8:00 AM EST
\n\n \n CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial - PR Newswire\n \n \n
\n\n Nov 25, 2008 8:01 AM EST
\n\n \n CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease - PR Newswire\n \n \n
\n\n Nov 13, 2008 8:00 AM EST
\n\n \n CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate - PR Newswire\n \n \n
\n\n Sep 09, 2008 8:31 AM EDT
\n\n \n CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial - PR Newswire\n \n \n
\n\n Jun 10, 2008 8:30 AM EDT
\n\n \n CVBT Inks Third Clinical Development Agreement - PR Newswire\n \n \n
\n
\n\n");